Author: openjargon

S&P/ASX All Ords Index (ASX: XAO) shares are in the red on Tuesday, down 1.11% to 8,870.1 points.

A small group of ASX shares have ex-dividend dates this month.

In order to receive a dividend, you must own the ASX share before its ex-dividend date.

So, if you’re looking for some extra income before the end of the financial year (EOFY), these ASX shares provide options.

Ex-dividend dates also provide another opportunity.

Share prices usually fall on ex-dividend dates, so you may be able to pick up a stock you’ve been watching for a lower price.

Among the shares going ex-dividend this month are ASX agriculture stock Select Harvests Ltd (ASX: SHV).

The almond producer will trade ex-dividend on 17 June and pay investors 3.5 cents per share on 15 July.

Bell Potter has a buy rating on Select Harvests shares with a 12-month price target of $5.30, compared with $3.86 currently.

ASX 200 iron ore share Champion Iron Ltd (ASX: CIA) has an ex-dividend date of 11 June and will pay 2 cents per share on 8 July.

RBC Capital has a buy rating on Champion Iron with an $8.11 target, compared to $4.30 per share today.

Several of Wilson Asset Management’s listed investment companies (LICs) will also go ex-dividend this month.

These include WCM Global Growth Ltd (ASX: WQG), which will trade ex-dividend on 10 June.

WCM Global Growth investors will receive a dividend of 2.2 cents per share on 30 June.

ASX shares with ex-dividend dates in June

ASX share	Ex-dividend date	Dividend amount	Pay day
Qualitas Real Estate Income Fund (ASX: QRI)	3 June	1.1 cents per share	15 June
Infratil Ltd (ASX: IFT)	9 June	9.5 cents per share	29 June
Tower Ltd (ASX: TWR)	10 June	4.1 cents per share	25 June
WCM Global Growth Ltd (ASX: WQG)	10 June	2.2 cents per share	30 June
Champion Iron Ltd (ASX: CIA)	11 June	2 cents per share	8 July
Future Generation Global Ltd (ASX: FGG)	11 June	3 cents per share	26 June
ALS Ltd (ASX: ALQ)	12 June	23.1 cents per share	3 July
Dyno Nobel Ltd (ASX: DNL)	12 June	4.6 cents per share	2 July
Transmetro Corporation Ltd (ASX: TCO)	15 June	6 cents per share	30 June
Select Harvests Ltd (ASX: SHV)	17 June	3.5 cents per share	15 July
WAM Active Ltd (ASX: WAA)	17 June	1 cents per share	30 June
WAM Income Maximiser Ltd (ASX: WMX)	17 June	0.006 cents per share	30 June
AFT Pharmaceuticals Ltd (ASX: AFP)	18 June	1.6 cents per share	3 July
Fisher & Paykel Healthcare Corporation Ltd (ASX: FPH)	22 June	27 cents per share	3 July
DPM Metals CDI (ASX: DPM)	29 June	4.1 cents per share	15 July

The post 15 ASX shares going ex-dividend before EOFY appeared first on The Motley Fool Australia.

More reading

• Champion Iron shares: Why the pressure could be temporary
• 5 ASX shares set to soar 40% to 80% in 12 months: experts
• Macquarie names 3 ASX 200 stocks to buy right now
• Why are these 3 ASX 200 stocks crashing in this week’s rebounding market?
• Why Champion Iron, IDP Education, Tuas, and Woodside shares are dropping today

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The S&P/ASX 200 Index (ASX: XJO) has fallen again in early morning trade on Tuesday as interest rate hike concerns, weaker commodity prices, and ongoing tension in the Middle East continue to put pressure on Australian stocks across several sectors.

But during periods of volatility, it’s important to look for investment opportunities that have strong outlooks. 

Here are four ASX 200 shares that brokers rate as strong buys, with potential upside of up to 51%.

Life360 Inc (ASX: 360)

The ASX 200 tech stock is trending higher so far in June, after falling just over 4% in May off the back of the latest tech-sector-wide sell-off. At the time of writing on Tuesday morning, Life360 shares are up around 10% and are changing hands for $22.35 a piece, and I think they can keep on climbing. The company reported a 38% increase in total revenue in its latest quarterly results, released in mid-May. This was primarily driven by a 32% increase in subscription revenue and 36% increase in core subscription revenue. Life360 also upgraded FY26 guidance for its revenue and adjusted EBITDA. Market Index data shows brokers rate the shares as a strong buy. They tip a 51% upside to $33.73, at the time of writing.

Alkane Resources Ltd (ASX: ALK)

The gold exploration and production company’s shares have fallen around 4% in Tuesday morning trade, to $1.47 a piece at the time of writing. The shares have rallied strongly over the past 12 months, however, and are currently trading around 88% higher than in early June last year. The miner’s diversity (it offers multimine gold and antimony exposure across three jurisdictions), strong balance sheet, and growth-focused operating platform are expected to drive the share price even higher. Brokers are bullish on the company’s outlook and rate the ASX 200 shares as a strong buy. They tip a 46% upside to $2.17 over the next 12 months.

Sigma Healthcare Ltd (ASX: SIG)

The ASX 200 healthcare shares are down around 2% in Tuesday morning trade to $2.86. It’s been a volatile start to the year for the company, with lower investor sentiment causing the shares to swing anywhere between a low of $2.60 and a high of $3.16. The outlook for the business looks good, though. The Chemist Warehouse owner posted a strong market update early last month, revealing a good operational performance and market momentum for the financial year through to 30 April 2026. The company also revealed plans to expand into the UK market. Brokers rate the shares as a strong buy and tip a 12% upside to $3.21 over the next 12 months.

Flight Centre Travel Group Ltd (ASX: FLT)

Flight Centre shares are also in the red this morning, down around 2% at the time of writing to $10.70 each. The dip means that the share price has now collapsed by around 35% from an annual high in February this year. But the company reported a strong third-quarter update in early May, despite ongoing travel disruptions and fuel supply challenges. Flight Centre also confirmed that its costs are now well below pre-pandemic levels, productivity is up across the business, and the company is on track to reach its full-year UPBT target of $315 million to $350 million. Brokers rate the ASX 200 shares as a strong buy and tip the stock to climb 47% to $15.61, at the time of writing.

The post 4 ASX 200 shares rated a strong buy and with upsides of up to 51% appeared first on The Motley Fool Australia.

More reading

• How to get wealthy investing $300 a month into ASX shares
• Here are the top 10 ASX 200 shares today
• Here are the 10 most shorted ASX shares
• Are these 2 oversold ASX shares too cheap to ignore in June?
• 3 ASX shares that brokers tipped to soar in the next 12 months

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Life360. The Motley Fool Australia has positions in and has recommended Life360. The Motley Fool Australia has recommended Flight Centre Travel Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Investing $300 a month may not sound dramatic.

But the share market does not need drama to build wealth. It needs time, consistency, and a sensible return.

Getting wealthy with ASX shares

If an investor put $300 a month into ASX shares and achieved an average annual return of 9%, the numbers could become surprisingly powerful.

After 10 years, the investment could be worth around $57,000.

After 20 years, it could grow to around $195,000.

After 30 years, it could reach roughly $515,000.

And after 40 years, it could become almost $1.3 million.

Those figures are not guaranteed. Markets will not deliver 9% every year in a neat line. But I think they show why regular investing can be so effective.

Why $300 a month can work

The early years can feel slow.

That is because the investor is doing most of the work at the beginning. The monthly contributions are larger than the returns being generated.

But over time, the balance shifts.

As the invested amount grows, the returns can start adding much more to the final outcome. A 9% return on $10,000 is $900. A 9% return on $500,000 is $45,000.

That is the same percentage return, but a very different dollar result.

This is why I think regular investing is so underrated. It does not require perfect timing. It simply requires putting money to work often enough and staying invested long enough for compounding to become more powerful.

What I’d look for

If I were investing $300 a month, I would focus on quality businesses with long growth runways.

That could include companies that already have strong positions but still have room to become more valuable over time.

Life360 Inc (ASX: 360) is one example of the sort of growth business I would study. It has a large global user base and multiple revenue streams from family safety, subscriptions, advertising, and connected services.

Breville Group Ltd (ASX: BRG) is another type of long-term compounder I like. Its strength is not just selling appliances. It is building a premium global brand around better design, performance, and habits, like at-home coffee.

I would also look at businesses with more defensive or repeat-purchase qualities. Coles Group Ltd (ASX: COL) may not deliver explosive growth, but groceries are a category households keep coming back to. That kind of steadiness can be useful over long periods.

Sigma Healthcare Ltd (ASX: SIG) is another interesting one because pharmacy, health, beauty, and wellness spending can be very regular. Scale, brand reach, and customer frequency can all become valuable when a business keeps executing.

And in financial services, Netwealth Group Ltd (ASX: NWL) is the sort of platform business I would watch closely. Advisers need efficient systems, clients need better investment administration, and wealth management continues to modernise.

I’d keep it flexible

The exact ASX shares do not need to stay the same forever.

A good investing habit should be flexible enough to improve over time. Some months may be better suited to exchange-traded funds (ETFs). Other months may offer better value in individual ASX shares.

What I would avoid is waiting for the perfect opportunity before starting. The longer an investor delays, the harder compounding has to work later.

Foolish Takeaway

Getting wealthy from $300 a month is not about finding one magic ASX share.

It is about turning investing into a repeatable habit and giving that habit decades to build momentum.

There will be market falls, disappointing company updates, and years where progress feels slow. But that is part of the process. If the money keeps going into quality opportunities and the investor stays patient, $300 a month can grow into a life-changing sum over time.

The post How to get wealthy investing $300 a month into ASX shares appeared first on The Motley Fool Australia.

More reading

• 4 ASX 200 shares rated a strong buy and with upsides of up to 51%
• Here are the top 10 ASX 200 shares today
• Leading brokers name 3 ASX shares to buy today
• Here’s how Coles and Woolworths shares stacked up in May
• Are these 2 oversold ASX shares too cheap to ignore in June?

Motley Fool contributor Grace Alvino has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Life360 and Netwealth Group. The Motley Fool Australia has positions in and has recommended Life360 and Netwealth Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The All Ordinaries Index (ASX: XAO) is down 0.9% in morning trade on Tuesday, but this junior ASX energy stock is heading the other direction.

And fast!

The rocketing stock in question is Energy World Corporation Ltd (ASX: EWC).

Energy World shares closed yesterday trading for 3.6 cents. At the time of writing, shares are changing hands for 8.4 cents apiece.

That sees shares in the ASX energy stock up a whopping 133.3% today.

Here’s what’s got investors overheating their buy buttons.

ASX energy stock surges on $489 million divestment news

Energy World shares are rocketing after the company announced an agreement to sell its Siemens gas and steam Turbines, located in the United States, to Hallador Energy Co (NASDAQ: HNRG).

The sale is expected to bring in gross proceeds of US$350 million (AU$489 million).

The ASX energy stock expects net proceeds of around US$331 million, after transaction costs. That’s assuming there are no material adjustments to the current baseline estimate of restoration costs.

Before completion of the sale, the gas turbines need to be inspected and refurbished by a recognised original equipment maintenance (OEM) provider.

The company said it has received an initial estimate from a recognised provider for the refurbishment costs based on a borescope inspection that was completed last year. The provider estimated that the required costs will be approximately US$22 million. It expects the works to take around 13 weeks to complete.

But management added that the final costs “remain subject to adjustment” following detailed inspection of the gas turbines.

The company also said that Hallador will deposit up to US$35 million into escrow to facilitate the packing and loading of the turbines.

Energy World noted it will book a non-cash impairment to the carrying value of the Power Plant assets of approximately US$285 million.

The company expects the sale to be recognised as part of its FY 2026 financial results.

What did Energy World management say?

Commenting on the sale that’s sending the ASX energy stock flying today, Energy World CEO Alan Jowell said:

The sale is an important transaction for EWC and demonstrates the company’s execution against a key element of its strategic review, namely the monetisation of selected assets to unlock value for shareholders.

Jowell added:

At the same time, global demand for gas turbines has strengthened considerably, driven by rapid growth in electricity demand from AI, data centres and cloud infrastructure.

Our turbines are unique in that they have never been fully installed, commissioned or fired and can be delivered within a relatively short timeframe, relative to widely reported lead times of five years or more for comparable new equipment from OEMs.

The post Guess which ASX energy stock is rocketing 133% today on huge US news! appeared first on The Motley Fool Australia.

More reading

• Which ASX lithium shares to buy as the market recovers: 2 brokers weigh in
• 15 ASX shares going ex-dividend before EOFY
• 4 ASX 200 shares rated a strong buy and with upsides of up to 51%
• How to get wealthy investing $300 a month into ASX shares
• Buy, hold, sell: 3 very popular ASX mining stocks

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

If you are looking for exposure to the mining sector, then it could pay to listen to what experts are saying about the ASX mining stocks in this article, courtesy of The Bull.

Here’s what they are saying about these stocks this week:

Arafura Rare Earths Ltd (ASX: ARU)

The team at Medallion Financial Group thinks Arafura Rare Earths is an ASX mining stock to hold.

While positive on its Nolans Project in the Northern Territory, it doesn’t appear to see enough value in its shares to recommend it as a buy. It said:

The rare earths company is developing the Nolans Project in the Northern Territory — Australia’s first fully integrated ore-to-oxide NdPr (Neodymium-Praseodymium) operation, producing the critical input for electric vehicle motors and wind turbines. With China controlling about 85 per cent of global processing and restricting exports, projects like Nolans are rare and strategically valuable. The company just reached its final investment decision and recently received commitments under an institutional placement to raise $350 million.

PLS Group Ltd (ASX: PLS)

Over at Catapult Wealth, it has named lithium giant PLS (formerly known as Pilbara Minerals) as a hold this week.

There is a lot to like about this ASX mining stock. However, it still isn’t quite enough for Catapult Wealth to give it a more positive recommendation. It said:

PLS is an Australian lithium producer, with its primary operation in Western Australia. PLS has a solid balance sheet. Revenue of $624 million in the first half of 2026 was up 47 per cent on the prior corresponding period. Driving growth is a combination of increasing demand for lithium and near term supply constraints. Demand is fuelled by growing battery and electric vehicle adoption, which has been boosted by the conflict in Iran and crude oil disruptions. The strong balance sheet and free cash flow should enable PLS to fund its expansion plans.

Unico Silver Ltd (ASX: USL)

Medallion Financial Group is more positive on this silver developer and has named it as an ASX mining stock to buy this week.

It likes the company due to its growing resource and exposure to a rising commodity. It explains:

This silver explorer is advancing high grade deposits in Argentina’s Santa Cruz province. The Joaquin project recently delivered a 143 per cent resource increase to 167 million ounces of silver equivalent since acquiring it in October 2024. The latest update was achieved from just 27,723 metres of drilling at a discovery cost of US11 cents per ounce. Silver demand is structurally supported by solar, electrification and green technology, giving USL direct leverage to a rising commodity. With the resource growing rapidly and development progressing, the investment case is building.

The post Buy, hold, sell: 3 very popular ASX mining stocks appeared first on The Motley Fool Australia.

More reading

• Which ASX lithium shares to buy as the market recovers: 2 brokers weigh in
• Top 10 ASX shares bought and sold by investors in May
• 3 ASX mining shares to buy: experts
• Buy, hold, sell: BHP, PLS Group, CBA shares
• How much could the PLS Group share price rise in the next year?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Megaport Ltd (ASX: MP1) shares are frozen on Tuesday after the cloud connectivity company requested a trading halt.

The Megaport share price last traded at $16.61.

The stock closed 7.02% higher on Monday, extending a huge month for shareholders.

Megaport shares are now up 86% over the past month, making it one of the best performers on the ASX.

The halt comes after Megaport told the ASX it is preparing an announcement on “new material commercial transactions”.

Here’s what we know so far.

Trading halt puts investors on alert

According to the release, Megaport requested the trading halt to manage its continuous disclosure obligations.

The company said the halt relates to an announcement on new material commercial transactions.

Unless the ASX decides otherwise, Megaport shares will remain halted until the earlier of the announcement being released or the start of normal trading on Thursday, 4 June 2026.

That gives the company up to 2 trading days to release the update, although it could land sooner.

At this stage, no key details have been announced to the market.

The trading halt notice does not include a confirmed customer name, contract value, revenue impact, or duration.

While that leaves plenty of room for speculation, investors will need the full release before deciding what to do next.

Why the market is watching Megaport

Megaport provides on-demand network and cloud connectivity services.

Its platform helps businesses connect to cloud providers, data centres, and other digital infrastructure without needing to build fixed private networks.

The company has also been attracting more attention from investors as demand grows across cloud, AI workloads, and enterprise connectivity.

When looking at the bigger picture, Megaport commands a market capitalisation of about $2.95 billion.

The stock also sits near the top of its 52-week range of $6.40 to $17.87.

Only a month ago, investors were paying more than a 60% discount for the same business.

After an 86% monthly gain, the market is clearly expecting more from the company.

Megaport’s H1 FY26 results showed annual recurring revenue above $338 million and more than 37,000 total services at the end of the first half.

It also had more than 1,100 enabled data centres, giving it a large footprint across global digital infrastructure markets.

Foolish Takeaway

Megaport shares were already running hot before the halt, with the stock up 22% over the past week.

A brief reference to new material commercial transactions will naturally raise expectations.

The risk is that a lot of good news may already be sitting in the share price after such a strong move.

Investors will be watching to see whether the announcement justifies the stock’s rapid climb.

The post Megaport shares halted after 86% surge. Is another major deal coming? appeared first on The Motley Fool Australia.

More reading

• Why did Megaport shares rocket 70% in May?
• Here are the top 10 ASX 200 shares today
• These were the best-performing ASX 200 shares in May
• Could this ASX 200 tech share be a hidden AI winner?
• Buy, hold, sell: Goodman, Megaport, and New Hope shares

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Megaport. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

It can be just as important to know which ASX shares to avoid as it is to know which ones to own when you are aiming to outperform the market.

That’s because if you own shares that are likely to fall in value, your portfolio returns could be dragged down along with them.

With that in mind, let’s look at three ASX 200 shares that analysts have named as sells this week, courtesy of The Bull. Here’s what they are bearish on:

A2 Milk Company Ltd (ASX: A2M)

Catapult Wealth has named A2 Milk shares as a sell this week. It has fears that a recent product recall could damage its brand image in the China market. In addition, the financial services company highlights that supply chain disruptions are constraining product availability. It said:

This infant milk formula company recently initiated a voluntary recall of three small batches of contaminated product sold only in the United States. While the recall didn’t impact the key Chinese market, it poses a reputational risk in a country and segment that is sensitive to brand reputation. A recent trading update revealed supply chain disruptions are constraining product availability despite strong underlying demand. The shares have remained under pressure since April when the company downgraded guidance in full year 2026.

Brambles Ltd (ASX: BXB)

The team at Red Leaf Securities is bearish on this logistics solutions company. As a result, it is recommending investors sell Brambles shares this week.

This is due to its belief that the ASX 200 share has gone from being a premium defensive compounder to a more challenged operational story. It explains:

This supply chain logistics giant has moved from a premium defensive compounder to a more challenged operational story following recent earnings and sales revenue downgrades. Disruptions in its United States pallet pooling network have exposed execution issues, resulting in higher costs. While the CHEP business model remains structurally sound, short term performance is weighed down by operational inefficiencies and inflationary pressures.

The downgrade cycle has shifted sentiment, with the market now questioning the sustainability of mid term growth expectations. Until execution stabilises and margins recover, Brambles lacks the earnings momentum required to justify a premium multiple, leaving risk skewed to the downside, in our view. The shares have fallen from $22.10 on May 15 to trade at $16.34 on May 28.

National Australia Bank Ltd (ASX: NAB)

Catapult Wealth has also named NAB shares as a sell this week. It was disappointed with the ASX 200 bank share’s performance in the first half.

And with trading conditions getting tough, it isn’t confident that NAB will be able to deliver on expectations. It said:

The bank’s first half result in fiscal year 2026 was underwhelming, in our view. Investment loans account for about a third of residential lending. Proposed changes to negative gearing and capital gains tax are likely to reduce loan and property price growth, in our view. Given higher interest rates and affordability pressures, NAB may struggle to deliver the growth needed to support current expectations.

The post 3 ASX 200 shares to sell this week according to experts appeared first on The Motley Fool Australia.

More reading

• Are ASX 200 bank shares a buy in June?
• Buy, hold, sell: Aristocrat Leisure, Brambles, Wesfarmers shares
• These were the worst-performing ASX 200 shares in May
• 5 ASX 200 shares downgraded by brokers this week
• Brambles shares have been smashed. Is this the support level to watch?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

4DMedical Ltd (ASX: 4DX) has launched a new clinical program which it says is designed to fast-track its entry into the large acute pulmonary embolism market.

The company’s shares jumped as high as $4.48 on the news before settling back to be 4.4% higher at $4.28.

Large market being targeted

4DMedical said in a statement to the ASX that CLEAR – contrast-free lung evaluation for acute risk in pulmonary embolism – was a clinical evidence program designed to fast-track its entry into the acute pulmonary embolism (PE) market, which would grow the addressable market for its CT:VQ product in the US to US$3 billion.

The company said PE accounts for about 600,000 to 650,000 diagnosed clinical episodes in the US per annum, with the true number of episodes likely much higher due to under-diagnosis.

The company added:

Because PE presents with non-specific symptoms such as chest pain and shortness of breath, and carries significant morbidity and mortality if untreated, clinical pathways are intentionally biased toward exclusion rather than confirmation. As a result, imaging volumes significantly exceed disease incidence.

4DMedical said CTPA – which its product could displace – had become the de facto imaging modality for suspected PE. This procedure involves injecting a contract dye into the bloodstream and taking x-ray scans.

Scan volumes had increased four-fold over the past 20 years or so, the company said.

The company added:

This persistent overuse has been accompanied by declining diagnostic efficiency. Across large cohorts, the positive diagnostic yield of CTPA has been reported in the range of approximately 3–10%, meaning the vast majority of patients (90-97%) undergo iodinated contrast exposure without confirmation of PE. Consequently, large volumes of patients are subjected to higher-cost imaging using contrast injections to rule-out PE as part of standard emergency and acute-care workflows.

4DMedical said there were an estimated five million CTPA scans carried out for suspected PE in the US each year.

Better outcome, less impact

Its CT:VQ product could achieve the same clinical outcome with less invasive scans, the company said.

CT:VQ generates quantitative, three-dimensional ventilation and perfusion maps from routine, non-contrast inspiratory and expiratory CT scans, enabling contrast-free functional lung assessment within standard CT workflows. Importantly, the underlying VQ (ventilation and perfusion) indication is already FDA-cleared, de-risking the regulatory pathway, while CLEAR generates the clinical evidence to drive adoption in acute PE. 4DMedical is already displacing nuclear VQ at pace. The Company believes the high-quality clinical evidence from CLEAR positions CT:VQ to extend beyond that core market into the materially larger (~5 million scans per annum in the U.S.) acute PE opportunity.

4DMedical also said it had entered into a clinical research agreement with Mass General Brigham at Massachusetts General Hospital – the largest teaching hospital of Harvard Medical School – to conduct the CLEAR program.

This will compare CT:VQ head to head with CTPA.

4DMedical is valued at $2.43 billion.

The post Why are 4DMedical shares charging higher today? appeared first on The Motley Fool Australia.

More reading

• Top 10 ASX shares bought and sold by investors in May
• Why 4DMedical, IperionX, Pro Medicus, and Ventia shaares are storming higher today
• This ASX healthcare rocket is up 14% in a week. Here’s why investors are still buying
• Here are the top 10 ASX 200 shares today
• Why 4DMedical, Elsight, Judo Capital, and Northern Star shares are racing higher today

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The ASX share market is always providing us with opportunities to consider. A large portion of my portfolio is focused on ASX dividend shares, and there are two names I’m planning to put money towards during June 2026.

I want to find investments that can provide a satisfactory level of passive income, payout growth and capital growth. I can use those dividends for my own life expenditure, or re-invest the dividends. Plus, long-term growth can help me become wealthier.

In the coming weeks, I’m planning to invest in the following two businesses.

MFF Capital Investments Ltd (ASX: MFF)

This business is best known as a listed investment company (LIC), led by portfolio manager Chris Mackay.

MFF likes to invest in a portfolio of global shares that have a combination of quality and value, while having the potential for self-reinforcing growth. It says it owns around 25 of the best listed businesses in the world.

Some of those holdings include Alphabet, Amazon, Mastercard and Visa.

By investing in businesses with excellent growth compounding potential, MFF has delivered excellent returns. Impressively, the ASX dividend share has delivered an average total shareholder return (TSR) of 15.2% per year over the prior five years, according to CMC Invest.

That return – which I think is a decent measure of portfolio performance – helps fund a higher dividend and supports MFF share price growth. The MFF share price has risen by 80% in the last five years, though past performance is not a guarantee of future performance, of course.

The ASX dividend share has increased its regular annual dividend per share each year since 2018 and it expects to increase its annual dividend per share to 21 cents per share for FY26. That translates into a grossed-up dividend yield of 6.1%, including franking credits.

L1 Long Short Fund Ltd (ASX: LSF)

The other ASX dividend share I’m considering is this LIC operated by L1 Group Ltd (ASX: L1G). I may decide to split any investing I do this month between the two names I’m highlighting in this article.

I like how the investment strategy includes investing in ASX shares and global shares, with both long-term buys and short-selling. This gives the LIC a wide range of opportunities to look at, with a particular focus on businesses with lower price/earnings (P/E) ratios, double-digit earnings per share (EPS) and modest debt levels.

The ASX dividend share’s portfolio has delivered an average net return per year of 16.3% over the prior five years, which is a great level of return to fund rising dividends. It has increased its annual dividend each year since 2021. The current trend of its quarterly dividend suggests the next year of dividends could equate to a grossed-up dividend yield of 5.2%, including franking credits, at the time of writing.

With a progressive dividend policy and good portfolio returns, the LIC has a very positive future, in my view.

The post 2 great ASX dividend shares I plan to buy in June appeared first on The Motley Fool Australia.

More reading

• Forget BHP shares! Buy these ASX dividend shares instead for passive income
• 3 ASX financial shares to buy: experts
• How much is needed in superannuation to target a $3,000 monthly passive income?
• Don’t want to rely on your wage? Build a second income with these ASX shares
• Buy, hold, sell: L1 Long Short Fund, Metcash, and Wesfarmers shares

Motley Fool contributor Tristan Harrison has positions in L1 Long Short Fund and Mff Capital Investments. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Alphabet, Amazon, Mastercard, and Visa. The Motley Fool Australia has recommended Alphabet, Amazon, Mastercard, Mff Capital Investments, and Visa. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are down 0.72% to 8,666.9 points on Tuesday.

The market is cautious as it continues to wait for further news on peace negotiations between the US and Iran.

Among the 11 market sectors, technology shares are in the lead, up 3.3%, while ASX REITs are the laggard, down 1.8%.

Meanwhile on the The Bull this week, two experts give us their views on three ASX 200 shares.

Let’s check them out. 

Commonwealth Bank of Australia (ASX: CBA)

The CBA share price is $161.02, down 1.4% today, and down 0.6% in the calendar year to date (YTD).

John Athanasiou from Red Leaf Securities has a hold rating on this ASX 200 bank share this week.

Athanasiou explains:

CBA remains the highest quality franchise in Australian banking, supported by its dominant deposit base, strong digital ecosystem and industry leading profitability.

Earnings remain resilient, but growth is moderating as mortgage competition intensifies and credit expansion normalises.

Credit quality is stable and dividends remain highly reliable, reinforcing its defensive appeal.

However, the key issue is valuation, with the stock trading at a significant premium to domestic and global peers.

Much of the quality and stability is already priced in, leaving limited upside without a material macro or earnings surprise to the upside.

Wesfarmers Ltd (ASX: WES)

The Wesfarmers share price is $78.90, down 1.1% today, and down 3.5% YTD.

Philippe Bui from Medallion Financial Group puts a sell rating on this ASX 200 consumer discretionary share this week.

Bui says:

Wesfarmers is a high quality business, but the outlook is softening, in our view.

A deteriorating consumer environment and sticky inflation are pressuring forward earnings, while Amazon‘s growing penetration across core retail categories is an intensifying competitive threat that shows no signs of abating.

Saluda Medical Inc (ASX: SLD)

The Saluda Medical share price is 43 cents, up 10.3% on no news today, and down 70% YTD.

Bui has a buy recommendation on this ASX healthcare share, and comments:

Saluda makes the Evoke spinal cord stimulator — the only closed loop device that automatically adjusts pain therapy in real time.

Clinical results are strong, with 90 per cent of patients preferring it to traditional systems.

Global revenue grew by 34 per cent in the third quarter of fiscal year 2026 when compared to the prior corresponding period.

Full year guidance has been upgraded twice since its initial public offering in calendar year 2025.

Given the share price fall since listing in December 2025, the valuation is compelling at current levels, in our view.

With no closed loop offering from competitors, acquisition interest is a real possibility.

The post Buy, hold, sell: Wesfarmers, Saluda Medical, CBA shares appeared first on The Motley Fool Australia.

More reading

• 2 ASX 200 shares I think could beat the market over 10 years
• Top 10 ASX shares bought and sold by investors in May
• Are ASX 200 bank shares a buy in June?
• Buy, hold, sell: Aristocrat Leisure, Brambles, Wesfarmers shares
• Buy, hold, sell: BHP, PLS Group, CBA shares

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Amazon and Wesfarmers. The Motley Fool Australia has recommended Amazon and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.